K E Yarasheski1, S Bhasin, I Sinha-Hikim, J Pak-Loduca, N F Gonzalez-Cadavid. 1. Kevin E.Yarasheski, PhD, Washington University Medical School, Division of Metabolism, Endocrinology and Diabetes, 660 South Euclid Avenue BOX 8127, St. Louis, MO 63110. Ph# 314-362-8173. FAX# 314-362-8188. e-mail:key@im.wustl.edu
Abstract
BACKGROUND: Myostatin is a recently discovered member of the TGF-b superfamily of genes. It is expressed in skeletal muscle and believed to suppress muscle growth. Myostatin-null mice develop skeletal muscles that are 2-3x larger than wild type mice. Serum and intramuscular concentrations of myostatin-immunoreactive protein are increased in AIDS-muscle wasting and are inversely related with fat-free mass (FFM). OBJECTIVE: We hypothesized that increased expression of the myostatin gene is associated with the reduction in FFM and muscle mass typical of advancing age. DESIGN: A cross-sectional comparison of serum myostatin-immunoreactive protein levels, FFM and skeletal muscle mass in 19-35 yr old men and women (young), healthy 60-75 yr old men and women (middle-aged), and physically frail 76-92 yr old women. RESULTS: Muscle mass declined with advancing age in both men and women. Serum myostatin-immunoreactive protein levels were the highest in the 76-92 yr old women (P<0.05). Middle-aged men and women had higher serum myostatin levels than young men and women (P<0.05). FFM and muscle mass, corrected for height, were inversely correlated with serum myostatin-immunoreactive protein concentrations. CONCLUSIONS: These findings suggest that serum myostatin may be a biomarker of age-associated sarcopenia. They are consistent with the hypothesis that the human myostatin gene product is a suppressor of skeletal muscle growth in advancing age.
BACKGROUND:Myostatin is a recently discovered member of the TGF-b superfamily of genes. It is expressed in skeletal muscle and believed to suppress muscle growth. Myostatin-null mice develop skeletal muscles that are 2-3x larger than wild type mice. Serum and intramuscular concentrations of myostatin-immunoreactive protein are increased in AIDS-muscle wasting and are inversely related with fat-free mass (FFM). OBJECTIVE: We hypothesized that increased expression of the myostatin gene is associated with the reduction in FFM and muscle mass typical of advancing age. DESIGN: A cross-sectional comparison of serum myostatin-immunoreactive protein levels, FFM and skeletal muscle mass in 19-35 yr old men and women (young), healthy 60-75 yr old men and women (middle-aged), and physically frail 76-92 yr old women. RESULTS: Muscle mass declined with advancing age in both men and women. Serum myostatin-immunoreactive protein levels were the highest in the 76-92 yr old women (P<0.05). Middle-aged men and women had higher serum myostatin levels than young men and women (P<0.05). FFM and muscle mass, corrected for height, were inversely correlated with serum myostatin-immunoreactive protein concentrations. CONCLUSIONS: These findings suggest that serum myostatin may be a biomarker of age-associated sarcopenia. They are consistent with the hypothesis that the humanmyostatin gene product is a suppressor of skeletal muscle growth in advancing age.
Authors: Nicole E Jensky; Jennifer K Sims; Judd C Rice; Hans C Dreyer; E Todd Schroeder Journal: Eur J Appl Physiol Date: 2007-07-28 Impact factor: 3.078
Authors: Rajani M George; Stefano Biressi; Brian J Beres; Erik Rogers; Amanda K Mulia; Ronald E Allen; Alan Rawls; Thomas A Rando; Jeanne Wilson-Rawls Journal: Proc Natl Acad Sci U S A Date: 2013-10-29 Impact factor: 11.205
Authors: Martine A I Thomis; Wim Huygens; Sofie Heuninckx; Monique Chagnon; Hermine H M Maes; Albrecht L Claessens; Robert Vlietinck; Claude Bouchard; Gaston P Beunen Journal: Eur J Appl Physiol Date: 2004-04-09 Impact factor: 3.078
Authors: I Carneiro; I Castro-Piedras; A Muñoz; J L Labandeira-García; J Devesa; V M Arce Journal: J Endocrinol Invest Date: 2008-09 Impact factor: 4.256